Literature DB >> 3188814

Evening urinary free corticoids: a screening test in Cushing's syndrome and incidentally discovered adrenal tumours.

M H Laudat1, L Billaud, P Thomopoulos, O Vera, A Yllia, J P Luton.   

Abstract

In this study, we investigated the usefulness of the determination of evening urinary free corticoids/creatinine in samples collected from 20.00 to 24.00 h as a screening test in Cushing's syndrome. In controls (N = 61) the ratio values ranged from 1.1 to 9.4 mumol/mol, whereas in patients with Cushing's syndrome (N = 20), they ranged from 27.5 to 855.5 mumol/mol. However, in 28% of patients with major obesity (greater than 50% overweight) and no hypercortisolism, the ratio values were between 9.4 to 27.8 mumol/mol. A short (10 days) hypocaloric diet induced a decrease in the values in 75% of these patients; the normal range was reached in 50% of them. In addition, the evening urinary free corticoids/creatinine was slightly abnormal in 8 out of 10 patients with incidentally discovered 'silent' adrenal adenomas, whereas it was normal in all 6 with other adrenal masses. In conclusion, evening urinary free corticoids/creatinine is easy to obtain and it reaches a higher sensitivity (100%) and specificity (97%) than the 24 h urinary free corticoids. In the case of borderline values, the presence of overweight should be taken into account.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3188814     DOI: 10.1530/acta.0.1190459

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  4 in total

Review 1.  The clinical evaluation of silent adrenal masses.

Authors:  B Ambrosi; E Passini; T Re; L Barbetta
Journal:  J Endocrinol Invest       Date:  1997-02       Impact factor: 4.256

2.  The midnight-to-morning urinary cortisol increment method is not reliable for the assessment of hypothalamic-pituitary-adrenal insufficiency in patients with end-stage kidney disease.

Authors:  Y Oguz; C Oktenli; M Ozata; T Ozgurtas; Y Sanisoglu; M Yenicesu; A Vural; F Bulucu; I H Kocar
Journal:  J Endocrinol Invest       Date:  2003-07       Impact factor: 4.256

Review 3.  Incidentalomas of the adrenal gland: 36 operated patients and review of literature.

Authors:  J E Sirén; R K Haapiainen; K T Huikuri; A H Sivula
Journal:  World J Surg       Date:  1993 Sep-Oct       Impact factor: 3.352

4.  Reliability of hormonal levels for assessing the hypothalamic-pituitary-adrenocortical system in clinical pharmacology.

Authors:  J Coste; G Strauch; M Letrait; X Bertagna
Journal:  Br J Clin Pharmacol       Date:  1994-11       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.